Santhera Pharmaceuticals Ag

(OTC) SPHDF

Current Price$23.25

Market Cap$330.70M

Since IPO (2009)-91%

5 Year-21%

1 Year+33%

1 Month+19%

Santhera Pharmaceuticals Ag Financials at a Glance

Market Cap

$330.70M

Revenue (TTM)

$116.33M

Net Income (TTM)

$91.21M

EPS (TTM)

$-4.50

P/E Ratio

-5.17

Dividend

$0.00

Beta (Volatility)

-0.05 (Low)

Dividend

$0.00

Beta (Volatility)

-0.05 (Low)

Price

$23.25

Volume

3,200

Open

$23.25

Price

$23.25

Volume

3,200

Open

$23.25

Previous Close

$23.25

Daily Range

$23.25 - $23.25

52-Week Range

$12.28 - $23.25

Dividend

$0.00

Beta (Volatility)

-0.05 (Low)

Price

$23.25

Volume

3,200

Open

$23.25

Previous Close

$23.25

Daily Range

$23.25 - $23.25

52-Week Range

$12.28 - $23.25

SPHDF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Santhera Pharmaceuticals Ag

Industry

Biotechnology

Sector

Health Care

Employees

93.6

CEO

Dario Eklund

Website

www.santhera.com

Headquarters

Pratteln, 4133, CH

SPHDF Financials

Key Financial Metrics (TTM)

Gross Margin

19%

Operating Margin

-49%

Net Income Margin

-64%

Return on Equity

-742%

Return on Capital

-44%

Return on Assets

-33%

Earnings Yield

-19.34%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$330.70M

Shares Outstanding

14.22M

Volume

3.20K

Avg. Volume

306.508

Financials (TTM)

Gross Profit

$14.47M

Operating Income

$37.83M

EBITDA

$32.14M

Operating Cash Flow

$34.78M

Capital Expenditure

$52.02K

Free Cash Flow

$34.83M

Cash & ST Invst.

$22.45M

Total Debt

$97.81M

Santhera Pharmaceuticals Ag Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$53.20M

-46.5%

Gross Profit

$22.93M

-76.6%

Gross Margin

43.11%

N/A

Market Cap

$330.70M

N/A

Market Cap/Employee

$4.24M

N/A

Employees

N/A

Net Income

$10.41M

-113.3%

EBITDA

$480.23K

-99.5%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$75.36M

-954.3%

Accounts Receivable

$26.05M

+5820.6%

Inventory

$24.88M

+1273.8%

Long Term Debt

$74.07M

+211532.8%

Short Term Debt

$23.74M

+10.4%

Return on Assets

-33.25%

N/A

Return on Invested Capital

-44.02%

N/A

Free Cash Flow

$14.22M

-122.7%

Operating Cash Flow

$14.17M

-122.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

SLNCFSilence Therapeutics plc

SLNCFSilence Therapeutics plc$2.36+0.00%

GNFTFGenfit S.A.

GNFTFGenfit S.A.$9.47-14.30%

IPHYFInnate Pharma S.A.

IPHYFInnate Pharma S.A.$1.50+9.29%

JWCTFJW (Cayman) Therapeutics Co. Ltd

JWCTFJW (Cayman) Therapeutics Co. Ltd$0.28+0.00%

MLLCFMolecular Partners AG

MLLCFMolecular Partners AG$2.55+0.00%

NDTPNDT Pharmaceuticals Inc.

NDTPNDT Pharmaceuticals Inc.$0.59+0.00%

BXPHFBotanix Pharmaceuticals Limited

BXPHFBotanix Pharmaceuticals Limited$0.02-11.56%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

CNSPCns Pharmaceuticals

CNSPCns Pharmaceuticals$8.48+2.67%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.21+0.01%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.74+0.01%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$45.65+0.03%

PNSkycorp Solar Group

PNSkycorp Solar Group$5.53+0.93%

NCLHNorwegian Cruise Line

NCLHNorwegian Cruise Line$17.09-0.09%

ADTADT

ADTADT$7.08-0.06%

Questions About SPHDF

What is the current price of Santhera Pharmaceuticals Ag?

Santhera Pharmaceuticals Ag is trading at $23.25 per share.

What is the 52-week range for Santhera Pharmaceuticals Ag?

Over the past 52 weeks, Santhera Pharmaceuticals Ag has traded between $12.28 and $23.25.

How much debt does Santhera Pharmaceuticals Ag have?

As of the most recent reporting period, Santhera Pharmaceuticals Ag reported total debt of $123.40M.

How much cash does Santhera Pharmaceuticals Ag have on hand?

Santhera Pharmaceuticals Ag reported $28.32M in cash and cash equivalents in its most recent financial results.

What is Santhera Pharmaceuticals Ag’s dividend yield?

Santhera Pharmaceuticals Ag does not currently have a dividend yield.

Santhera Pharmaceuticals Ag

Santhera Pharmaceuticals Ag Financials at a Glance

SPHDF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Santhera Pharmaceuticals Ag

SPHDF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Santhera Pharmaceuticals Ag Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About SPHDF

What is the current price of Santhera Pharmaceuticals Ag?

What is the 52-week range for Santhera Pharmaceuticals Ag?

How much debt does Santhera Pharmaceuticals Ag have?

How much cash does Santhera Pharmaceuticals Ag have on hand?

What is Santhera Pharmaceuticals Ag’s dividend yield?

Premium Investing Services